Alzamend Neuro Inc (ALZN)

Alzamend Neuro Inc Azioni (ALZN) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	8.33% 2.6599	2.9017	3.5259	-	-
Interest Income/Expense	42.29% 0.00249	0.00431	0.00184	0.000519	0.00206
Operating Income/Loss	8.33% -2.6599	-2.9017	-3.5259	-3.305	-5.4235
Nonoperating Income/Loss	42.29% -0.00249	-0.00431	-0.00184	-0.000519	-0.00206
Income/Loss From Continuing Operations Before Tax	192.91% 2.70	-2.906	3.50	-26.48	5.40
Income/Loss From Continuing Operations After Tax	192.91% 2.70	-2.906	3.50	-26.48	5.40
Net Income/Loss	192.91% 2.70	-2.906	3.50	3.30	5.40
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	5.3624	-	7.0278	6.6055	10.83
Basic Average Shares	7.47% 7.0543	6.5638	98.44	-	-
Diluted Average Shares	7.47% 7.0543	6.5638	98.44	-0.2465	98.33
Basic Earnings Per Share	13.64% -0.38	-0.44	-0.04	-0.03	-0.06
Diluted Earnings Per Share	13.64% -0.38	-0.44	-0.04	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-